These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 19665375)

  • 1. Synthesis of novel ageladine A analogs showing more potent matrix metalloproteinase (MMP)-12 inhibitory activity than the natural product.
    Ando N; Terashima S
    Bioorg Med Chem Lett; 2009 Sep; 19(18):5461-3. PubMed ID: 19665375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and matrix metalloproteinase (MMP)-12 inhibitory activity of ageladine A and its analogs.
    Ando N; Terashima S
    Bioorg Med Chem Lett; 2007 Aug; 17(16):4495-9. PubMed ID: 17574851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and matrix metalloproteinase-12 inhibitory activity of ageladine A analogs.
    Ando N; Terashima S
    Chem Pharm Bull (Tokyo); 2011; 59(5):579-96. PubMed ID: 21532196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A one-pot synthesis and biological activity of ageladine A and analogues.
    Shengule SR; Loa-Kum-Cheung WL; Parish CR; Blairvacq M; Meijer L; Nakao Y; Karuso P
    J Med Chem; 2011 Apr; 54(7):2492-503. PubMed ID: 21413800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total synthesis of ageladine A, an angiogenesis inhibitor from the marine sponge Agelas nakamurai.
    Meketa ML; Weinreb SM
    Org Lett; 2006 Mar; 8(7):1443-6. PubMed ID: 16562912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of a 6pi-1-azatriene electrocyclization strategy to the total synthesis of the marine sponge metabolite ageladine A and biological evaluation of synthetic analogues.
    Meketa ML; Weinreb SM; Nakao Y; Fusetani N
    J Org Chem; 2007 Jun; 72(13):4892-9. PubMed ID: 17539689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concise total synthesis of the marine natural product ageladine A.
    Shengule SR; Karuso P
    Org Lett; 2006 Aug; 8(18):4083-4. PubMed ID: 16928079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ageladine A: an antiangiogenic matrixmetalloproteinase inhibitor from the marine sponge Agelas nakamurai.
    Fujita M; Nakao Y; Matsunaga S; Seiki M; Itoh Y; Yamashita J; Van Soest RW; Fusetani N
    J Am Chem Soc; 2003 Dec; 125(51):15700-1. PubMed ID: 14677933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and target identification of hymenialdisine analogs.
    Wan Y; Hur W; Cho CY; Liu Y; Adrian FJ; Lozach O; Bach S; Mayer T; Fabbro D; Meijer L; Gray NS
    Chem Biol; 2004 Feb; 11(2):247-59. PubMed ID: 15123286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nagelamide J, a novel dimeric bromopyrrole alkaloid from a sponge Agelas species.
    Araki A; Tsuda M; Kubota T; Mikami Y; Fromont J; Kobayashi J
    Org Lett; 2007 Jun; 9(12):2369-71. PubMed ID: 17503838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The identification of beta-hydroxy carboxylic acids as selective MMP-12 inhibitors.
    Holmes IP; Gaines S; Watson SP; Lorthioir O; Walker A; Baddeley SJ; Herbert S; Egan D; Convery MA; Singh OM; Gross JW; Strelow JM; Smith RH; Amour AJ; Brown D; Martin SL
    Bioorg Med Chem Lett; 2009 Oct; 19(19):5760-3. PubMed ID: 19703773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel C-6 substituted and unsubstituted pregnane derivatives as 5alpha-reductase inhibitors and their effect on hamster flank organs diameter size.
    Cabeza M; Zambrano A; Heuze I; Carrizales E; Palacios A; Segura T; Valencia N; Bratoeff E
    Steroids; 2009 Oct; 74(10-11):793-802. PubMed ID: 19406144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and anticancer activities of ageladine A and structural analogs.
    Ma Y; Nam S; Jove R; Yakushijin K; Horne DA
    Bioorg Med Chem Lett; 2010 Jan; 20(1):83-6. PubMed ID: 19948404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total synthesis and biological evaluation of the marine bromopyrrole alkaloid dispyrin: elucidation of discrete molecular targets with therapeutic potential.
    Kennedy JP; Brogan JT; Lindsley CW
    J Nat Prod; 2008 Oct; 71(10):1783-6. PubMed ID: 18800848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Debromodispacamides B and D: isolation from the marine sponge Agelas mauritiana and stereoselective synthesis using a biomimetic proline route.
    Vergne C; Appenzeller J; Ratinaud C; Martin MT; Debitus C; Zaparucha A; Al-Mourabit A
    Org Lett; 2008 Feb; 10(3):493-6. PubMed ID: 18171071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.
    Nuti E; Panelli L; Casalini F; Avramova SI; Orlandini E; Santamaria S; Nencetti S; Tuccinardi T; Martinelli A; Cercignani G; D'Amelio N; Maiocchi A; Uggeri F; Rossello A
    J Med Chem; 2009 Oct; 52(20):6347-61. PubMed ID: 19775099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ageladine A, a pyrrole-imidazole alkaloid from marine sponges, is a pH sensitive membrane permeable dye.
    Bickmeyer U; Grube A; Klings KW; Köck M
    Biochem Biophys Res Commun; 2008 Aug; 373(3):419-22. PubMed ID: 18588854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of an orally efficacious matrix metalloprotease 12 inhibitor for potential treatment of asthma.
    Li W; Li J; Wu Y; Rancati F; Vallese S; Raveglia L; Wu J; Hotchandani R; Fuller N; Cunningham K; Morgan P; Fish S; Krykbaev R; Xu X; Tam S; Goldman SJ; Abraham W; Williams C; Sypek J; Mansour TS
    J Med Chem; 2009 Sep; 52(17):5408-19. PubMed ID: 19725580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nagelamides K and L, dimeric bromopyrrole alkaloids from sponge Agelas species.
    Araki A; Kubota T; Tsuda M; Mikami Y; Fromont J; Kobayashi J
    Org Lett; 2008 Jun; 10(11):2099-102. PubMed ID: 18454539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel class of positive allosteric modulators of AMPA receptors: design, synthesis, and structure-activity relationships of 3-biphenyl-4-yl-4-cyano-5-ethyl-1-methyl-1H-pyrrole-2-carboxylic acid, LY2059346.
    Zarrinmayeh H; Tromiczak E; Zimmerman DM; Rankl N; Ho KH; Dominguez E; Castaño A; Escribano A; Fernandez C; Jimenez A; Hornback WJ; Nisenbaum ES
    Bioorg Med Chem Lett; 2006 Oct; 16(19):5203-6. PubMed ID: 16872827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.